EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

3D genome architecture and epigenetic regulation of lineage identity in advanced prostate cancer

Songyan Qi, Scott M Dehm iD

Endocrinology · 26.05.2026 · 167 (7)

DOI: 10.1210/endocr/bqag068 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology, online erschienen am 17.06.2026. Verfasst von Songyan Qi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Genome. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer development and progression depend on androgen receptor (AR) signaling. Therefore, androgen-deprivation therapy (ADT) and AR signaling inhibitors (ARSIs) are standard therapies for advanced or metastatic disease. Although these treatments are initially effective, prostate cancer inevitably progresses to a lethal stage termed castration-resistant prostate cancer (CRPC). In the majority of patients, CRPC occurs via reactivation of AR signaling (CRPC-AR). However, lineage plasticity is a hallmark of cancer that drives AR-independent CRPC phenotypes in a subset of patients. One subtype of AR-negative CRPC is neuroendocrine prostate cancer (NEPC), which transforms from CRPC-AR by losing the characteristic AR-driven luminal epithelial identity and gaining neuroendocrine identity. Another AR-negative CRPC subtype lacks AR and neuroendocrine features and has therefore been classified as double-negative prostate cancer (DNPC). Chromatin modifications, alterations in three-dimensional (3D) genome structure, and expression of transcriptional regulators are crucial for controlling lineage states and modulating AR-dependent and AR-independent phenotypes in CRPC. Here, we highlight how high-resolution investigations of the 3D genome have revealed interdependence between chromatin architecture and transcriptional regulation, offering novel insights into the mechanisms of CRPC progression and context-specific targets for therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticProstatic NeoplasmsProstatic Neoplasms, Castration-ResistantGenomeHumansMaleReceptors, AndrogenGene Expression Regulation, NeoplasticCell LineageAnimalsChromatinSignal Transduction

Stichwörter der Autor:innen

3D chromatinepigeneticlineage plasticityprostate cancer

Substanzen

Receptors, AndrogenChromatin

Autor:innen und Institutionen

  • Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
  • Graduate Program in Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
  • Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA.
  • Department of Urology, University of Minnesota, Minneapolis, MN 55455, USA.

ORCID-Profile: Scott M Dehm

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Qi, S., & Dehm, S. M. (2026). 3D genome architecture and epigenetic regulation of lineage identity in advanced prostate cancer. Endocrinology, 167(7). https://doi.org/10.1210/endocr/bqag068

Vancouver

Qi S, Dehm SM. 3D genome architecture and epigenetic regulation of lineage identity in advanced prostate cancer. Endocrinology. 2026;167(7). doi:10.1210/endocr/bqag068

BibTeX
@article{Qi2026,
  author = {Qi, Songyan and Dehm, Scott M},
  title = {3D genome architecture and epigenetic regulation of lineage identity in advanced prostate cancer},
  journal = {Endocrinology},
  year = {2026},
  volume = {167},
  number = {7},
  doi = {10.1210/endocr/bqag068}
}
Kostenlos starten →